Angeion
This article was originally published in The Gray Sheet
Executive Summary
Implantable cardioverter defibrillator maker is released from financial and regulatory obligations related to its joint venture with ELA Medical for ICD distribution, the company says May 12. ELA continues to distribute Angeion ICDs and leads in the U.S. and Europe under an amended supply agreement